首页> 外文期刊>Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation >High prevalence of sleep disorders in hemodialyzed patients requiring parathyroidectomy.
【24h】

High prevalence of sleep disorders in hemodialyzed patients requiring parathyroidectomy.

机译:需要进行甲状旁腺切除术的血液透析患者的睡眠障碍患病率较高。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: Although there has been contrasting evidence for a causative role of parathyroid hormone (PTH) in sleep disorders in patients on maintenance hemodialysis, a recent study disclosed the possibility that this role might exist at least in patients requiring parathyroidectomy because of failure of medical therapy. The present study was devised to assess a possible difference in sleep disorders of patients on hemodialysis needing parathyroidectomy and those in whom medical therapy controlled hyperparathyroidism. DESIGN AND PATIENTS: To this end, a group of 22 patients requiring parathyroidectomy were studied by means of a sleep questionnaire, along with a group of 44 patients matched for age, gender, body weight, and duration of dialytic treatment. RESULTS: Patients requiring parathyroidectomy slept fewer hours (P < .001), had a higher prevalence of sleep disorders (P < .001), and were more often insomniac (P < .001). CONCLUSIONS: This study indicates that patients on hemodialysis requiring parathyroidectomy for intractable hyperparathyroidism comprise a good model for investigating the causative role of PTH on disordered sleep, and that these patients have very poor sleep. These data support recent findings on the prevalence of sleep disorders in dialyzed patients with insuppressible hyperparathyroidism.
机译:目的:尽管有相反的证据表明维持性血液透析患者的甲状旁腺激素(PTH)在睡眠障碍中具有致病作用,但最近的一项研究揭示了至少由于药物治疗失败而需要甲状旁腺切除术的患者可能存在这种作用的可能性。 。本研究旨在评估需要进行甲状旁腺切除术的血液透析患者和药物治疗可控制甲状旁腺功能亢进的患者睡眠障碍的可能差异。设计和患者:为此,通过睡眠调查表对22例需要进行甲状旁腺切除术的患者进行了研究,并对44例年龄,性别,体重和透析治疗时间相匹配的患者进行了研究。结果:需要进行甲状旁腺切除术的患者睡眠时间较少(P <.001),睡眠障碍患病率较高(P <.001),失眠症的发生频率较高(P <.001)。结论:这项研究表明,需要进行甲状旁腺切除术以治疗顽固性甲状旁腺功能亢进的血液透析患者,是研究PTH对睡眠障碍的致病作用的良好模型,并且这些患者的睡眠非常差。这些数据支持了对不可抑制的甲状旁腺功能亢进的透析患者中​​睡眠障碍患病率的最新发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号